TITLE

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010

PUB. DATE
January 2011
SOURCE
MMWR: Morbidity & Mortality Weekly Report;1/14/2011, Vol. 60 Issue 1, p13
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents the updated recommendations issued by the U.S. Advisory Committee on Immunization Practices for the use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine. The recommended Tdap dose for children and adults is presented. The two Tdap vaccines that are available in the U.S. are Boostrix from GlaxoSmithKline Biologicals and Adacel from Sanofi Pasteur. The safety, immunogenicity, and guidance for use of Tdap vaccines for children, adults and undervaccinated children are summarized.
ACCESSION #
57850207

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics